Findings

What do systematic reviews say?

150 questions · 154 findings · 22 reviews · Eyes and Vision

Sort:Best matchNewest Highest certainty Download CSV

No studies found 6 · 3.9%GRADE not reported 3 · 1.9%Very low 44 · 28.6%Low 50 · 32.5%Moderate 48 · 31.2%High 3 · 1.9%

Intervention not reported

Brolucizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 369 participants
Low

Intervention not reported

Conbercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 125 participants
Very low

Intervention not reported

Faricimab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1262 participants
Low

Intervention not reported

Ranibizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 1501 participants
Very low

Intervention not reported

Ranibizumab deferred laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 139 participants
Low

Intervention not reported

Ranibizumab prompt laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 287 participants
Very low

Intervention not reported

Laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 598 participants
Low

Intervention not reported

Faricimab (PTI) · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 632 participants
Moderate

Intervention not reported

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1592 participants
Moderate

Intervention not reported

Brolucizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 368 participants
Moderate

Intervention not reported

High‐dose atropine (≥ 0.5%) · children with progressive myopia (38 studies, 6525 participants in analyses) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 512 participants
Moderate

Intervention not reported

Undercorrected single vision spectacles · children with progressive myopia (38 studies, 6525 participants in analyses) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 72 participants
Low

Intervention not reported

High‐dose atropine (≥ 0.5%) · children with progressive myopia (26 studies, 4949 participants in the analysis) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 428 participants
Moderate

Intervention not reported

Moderate‐dose atropine (0.1% to < 0.5%) · children with progressive myopia (26 studies, 4949 participants in the analysis) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 247 participants
Low

Intervention not reported

Low‐dose atropine (< 0.1%) · children with progressive myopia (26 studies, 4949 participants in the analysis) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 249 participants
Low

Intervention not reported

Pirenzepine · children with progressive myopia (26 studies, 4949 participants in the analysis) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 53 participants
Low

Intervention not reported

Multifocal soft contact lenses · children with progressive myopia (26 studies, 4949 participants in the analysis) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 540 participants
Low

Intervention not reported

Rigid gas‐permeable contact lenses · children with progressive myopia (26 studies, 4949 participants in the analysis) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 154 participants
Very low

Intervention not reported

Peripheral plus spectacle lenses · children with progressive myopia (26 studies, 4949 participants in the analysis) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 188 participants
Very low

Intervention not reported

Multifocal spectacle lenses · children with progressive myopia (26 studies, 4949 participants in the analysis) Interventions: optical and pharmacological Comparator:…

1 finding from 1 review

Interventions for myopia control in children: a living systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 696 participants
Low